Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.
about
Impact of newer pharmacological treatments on quality of life in patients with Parkinson's diseaseThe hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'Levodopa in the treatment of Parkinson's disease: current controversies.Other pharmacological treatments for motor complications and dyskinesias.Medicine-taking behavior: implications of suboptimal compliance in Parkinson's disease.Advances in the delivery of treatments for Parkinson's disease.The levodopa wearing-off phenomenon in Parkinson's disease: pharmacokinetic considerations.Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?Impact of Duodopa on Quality of Life in Advanced Parkinson's Disease: A UK Case Series.Duodenal levodopa infusion for the treatment of Parkinson's disease.Treatment of levodopa-induced motor complications.Perspectives on recent advances in the understanding and treatment of Parkinson's disease.Managing the critical problems of advanced Parkinson's disease.Therapeutic options for continuous dopaminergic stimulation in Parkinson's diseaseTherapies for dopaminergic-induced dyskinesias in Parkinson disease.Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression.Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.Novel formulations and modes of delivery of levodopa.Carbidopa levodopa enteral suspension.A review of current and novel levodopa formulations for the treatment of Parkinson's disease.Short-term cost and health consequences of duodenal levodopa infusion in advanced Parkinson's disease in Sweden: an exploratory study.Continuous levodopa for advanced Parkinson's disease.Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study.Duodenal levodopa infusion in Parkinson's disease--long-term experience.Oral solution of levodopa ethylester for treatment of response fluctuations in patients with advanced Parkinson's disease.Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease.Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test.Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?Levodopa: A new look at an old friend.Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy.Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care.Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study.Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients.Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa.Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.Levodopa ethylester: a novel rescue therapy for response fluctuations in Parkinson's disease.Infusion-rate-dependent Acute Neuropathic Pain with Duopa in a Patient with Parkinson's Disease and Pre-existing Neuropathy
P2860
Q28283547-B1E78F76-66E4-4523-A467-FA1287A7DD17Q30248922-6ECB6D08-A1C8-4F1A-ACC3-591FE2DDD295Q33260251-0A35CDEE-2093-4A1B-85CA-05B8D8D97362Q35889917-E21C3CF3-9425-4E8C-9465-DF31A7FE34AAQ36094528-BF654D37-D77A-4843-9FD2-42ED8EC38762Q36224243-ACBAEF6E-5D6F-4A59-8F50-549AF760F7FBQ36316936-CBFE25AD-EFA0-4EBC-B9D9-7461B68528A7Q36521884-A7AEA2EB-D327-4858-8621-D2F7577F50BDQ36587747-E4D83D3B-9C63-4422-83C2-2ECD050B04F4Q36651313-0737CDC9-8817-4EDC-B83E-2ED3A4A8AF38Q36765792-7F1B8F43-1E0D-4E1F-A519-99084F32C285Q37264482-7B3F7605-A63B-48E2-A898-5C62E7FB3D73Q37590405-A0696A78-931A-4E7F-8FCB-A00065026D93Q37610215-126DD506-0E18-452F-8F29-FD1F1E7BC917Q37823337-FBA1D981-4F81-48C0-875A-6811D9CB5B79Q37890986-C1A9AA82-A64C-460D-88B2-C1C8146BBAABQ37924626-125D366D-192C-4DF1-88A9-7F0D6BBC97DBQ38070888-280E4B01-1A4E-4637-ABF3-1884747AA734Q38262418-52F1F26A-E89C-4A4F-B1B6-2FC26B9F530CQ38283415-F1E0B166-1133-4A1C-868A-52435A265CB2Q38643494-C386B5E1-5481-40BC-80C2-BC35FA409D09Q38740274-D5A07F77-8AA4-42AD-8028-FBD62AB2445FQ39942155-9F0E17B6-2132-44DC-8584-0C105FF77164Q41825026-37F8EE6B-9C45-4D6C-8053-A50A698E4BEDQ43003720-60F24D57-D9F0-4AB6-9B2F-128D57424F8DQ43923057-E7F6E191-FC02-42D7-A8CE-FFF14FBEC473Q43938514-38F9718E-FAB6-46E4-B9B5-6B6CF1D7B32DQ45772315-A2D40AB1-2688-4316-8E22-1EC5474F1613Q45941262-FD0BF2B1-64D5-4F23-901D-471FD08E2BEAQ46716788-27E7A2D4-94B8-458B-A823-E4E6BDB6A4EDQ47652358-A2AAE167-D4FC-4DC7-A2E2-623B45964787Q47948932-BED6E813-6597-4264-B26B-AC5FC96E924AQ47962428-74F20F39-EA2C-4CAD-9349-F62427745F66Q48258968-4DFC4F4F-7D1C-4E9F-AB01-40E035FBC272Q48419574-8C2D5AD9-AADD-4FFC-8F7C-43F336B228E5Q50666990-26D00314-CB9C-4765-8F1F-95429CB8FAF0Q53143036-65C9DDD4-23C2-4CC9-836F-ECDE88D24883Q53182761-D7757BB3-16C7-4D72-91DA-43EF7CD95CFCQ53991374-49860D69-58FC-4A7C-A350-BCE20439F720Q57138445-EFDF7BD6-EEE5-4A80-AF65-86528DE3616F
P2860
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuations.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Double-blind, placebo-controll ...... ts with 'on-off' fluctuations.
@en
Double-blind, placebo-controll ...... ts with 'on-off' fluctuations.
@nl
type
label
Double-blind, placebo-controll ...... ts with 'on-off' fluctuations.
@en
Double-blind, placebo-controll ...... ts with 'on-off' fluctuations.
@nl
prefLabel
Double-blind, placebo-controll ...... ts with 'on-off' fluctuations.
@en
Double-blind, placebo-controll ...... ts with 'on-off' fluctuations.
@nl
P2093
P921
P356
P1433
P1476
Double-blind, placebo-controll ...... ts with 'on-off' fluctuations.
@en
P2093
P304
P356
10.1212/WNL.43.9.1698
P407
P577
1993-09-01T00:00:00Z